What is Design Therapeutics, Inc. Common Stock's Market Cap?

Design Therapeutics, Inc. Common Stock's Market Cap is $640.8M, based on as-reported figures from SEC (XBRL) filings.

What is Design Therapeutics, Inc. Common Stock's Enterprise Value?

Design Therapeutics, Inc. Common Stock's Enterprise Value is $433.4M, based on as-reported figures from SEC (XBRL) filings.

What is Design Therapeutics, Inc. Common Stock's EV / EBITDA?

Design Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Design Therapeutics, Inc. Common Stock's Revenue (TTM)?

Design Therapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Design Therapeutics, Inc. Common Stock's Net Income (TTM)?

Design Therapeutics, Inc. Common Stock's Net Income (TTM) is -$70.8M, based on as-reported figures from SEC (XBRL) filings.

What is Design Therapeutics, Inc. Common Stock's EBITDA?

Design Therapeutics, Inc. Common Stock's EBITDA is -$78.7M, based on as-reported figures from SEC (XBRL) filings.

What is Design Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Design Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.13, based on as-reported figures from SEC (XBRL) filings.

What is Design Therapeutics, Inc. Common Stock's Net Debt?

Design Therapeutics, Inc. Common Stock's Net Debt is -$207.4M, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

Design Therapeutics, Inc. Common Stock

XNAS · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00SNC49W7

10.24▼ 0.25 (-2.38%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales: —
EV / Revenue: —
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin: —
Net Debt

Trading Information

Previous Close: 10.49
Day's Range: 10.10 – 10.42
52-Week Range: 5.40 – 17.25
Volume: 210.4K
Avg Volume: 656.7K

Share Statistics

Shares Outstanding
Employees: 54
Exchange: XNAS
Listed: 2021-03-26

Share count as of July 29, 2026

Design Therapeutics, Inc. Common Stock (DSGN) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Design Therapeutics, Inc. Common Stock (DSGN)

What is Design Therapeutics, Inc. Common Stock's Market Cap?: Design Therapeutics, Inc. Common Stock's Market Cap is $640.8M, based on as-reported figures from SEC (XBRL) filings.
What is Design Therapeutics, Inc. Common Stock's Enterprise Value?: Design Therapeutics, Inc. Common Stock's Enterprise Value is $433.4M, based on as-reported figures from SEC (XBRL) filings.
What is Design Therapeutics, Inc. Common Stock's EV / EBITDA?: Design Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Design Therapeutics, Inc. Common Stock's Revenue (TTM)?: Design Therapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Design Therapeutics, Inc. Common Stock's Net Income (TTM)?: Design Therapeutics, Inc. Common Stock's Net Income (TTM) is -$70.8M, based on as-reported figures from SEC (XBRL) filings.
What is Design Therapeutics, Inc. Common Stock's EBITDA?: Design Therapeutics, Inc. Common Stock's EBITDA is -$78.7M, based on as-reported figures from SEC (XBRL) filings.
What is Design Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Design Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.13, based on as-reported figures from SEC (XBRL) filings.
What is Design Therapeutics, Inc. Common Stock's Net Debt?: Design Therapeutics, Inc. Common Stock's Net Debt is -$207.4M, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · DSGNAs-filed SEC (XBRL) data